Rosetta Genomics Reports First Payment From the UK’s National Health …
The accurate identification of the primary tumor type in primary and metastatic cancer including cancer of unknown or uncertain primary is important in guiding clinician treatment decision John Bridgewater, M.D., University College London Hospital, UCL…